Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia

Total article views   HTML views PDF downloads Totals
2,993 Dovepress* 2,829+ 436 3,265
PubMed Central* 164 50 214
Totals 2,993 486 3,479
*Since 8 June 2021

View citations on PubMed Central and Google Scholar